General Information
Lilly DM2 GPGH
A Randomized, Phase 3, Open-label Trial Comparing the Effect of Tirzepatide versus Titrated Insulin Degludec on Glycemic Control in Patients with Type 2 Diabetes on Metformin with or without SGLT-2 Inhibitors
| Protocol | I8F-MC-GPGH |
|---|---|
| Identifier | PO 4900686591 |
| UID | 74da8352-d605-45db-a4d4-c9b73a0c37eb |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2019 |
| NCT Number | - |
| Created | 2018-08-13 10:57 |
| Last Updated | 2018-08-13 10:57 |
Description
No description provided.
Comment
CRI
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2019-11-12 | No |
| Enrollment Open | 2019-04-02 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2019-03-28 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2021-02-25 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Rocha, Luis | LRocha | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Eli Lilly and Company |
|---|---|
| Division | Lilly |
| Team | Lilly |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
